The US Food and Drug Administration (FDA) admonished Sun Pharmaceutical Industries in a recent warning ... These violations prompted FDA to place the firm on import alert on 7 December. FDA inspected ...

the FDA has highlighted a series of lapses at Sun Pharma’s Gujarat plant, which has been put on an import alert list by the US drug regulator.#sunpharma #halolfacility #usfda #cnbctv18 # ...

In a warning letter, the FDA has highlighted a series of lapses at Sun Pharma’s Gujarat plant, which has been put on an import alert list by the US drug regulator. In the letter dated December ...

For the US import alert to be lifted, Sun Pharma must conduct an independent, retrospective assessment of its cleaning effectiveness and cross-contamination hazards. The company was given 15 working ...

India's largest drugmaker Sun Pharmaceuticals Ltd. is likely to report a healthy quarter despite the weakness from its ...

Sun Pharmaceutical Industries posted a 5.2 percent year-on-year (YoY) rise in net profit for the third quarter of Financial Year 2022-23 to Rs 2,166 crore, riding on the back of sales in India and the ...

Sun Pharmaceutical Industries Ltd , India's largest drugmaker by revenue, reported a better-than-expected 5.2% rise in ...

Sun Pharma has acquired Disperzyme, Disperzyme-CD, and Phlogam as part of the deal. Drug major Sun Pharma Industries on Monday said it has acquired three anti-inflammatory brands ...

Pharmaceutical major Sun Pharma on Monday announced that it has acquired three brands--Disperzyme, Disperzyme-CD, and Phlogam from Aksigen Hospital Care. In a BSE stock filing, Sun Pharma informed ...

Defence Secretary Ben Wallace demanded a meeting and “assurances about future work” after The Sun raised the alarm. A Navy source said he was furious Babcock, one of the UK’s biggest defence ...